A review on potential of PARP inhibitors in the treatment of prostate cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Hoofdauteur: | Islam, Saidul |
---|---|
Andere auteurs: | Sharmin, Shahana |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
Brac University
2022
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/17308 |
Gelijkaardige items
-
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
door: Karim, Azrin
Gepubliceerd in: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Flora, Sanzida Alam
Gepubliceerd in: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
door: Meem, Manila
Gepubliceerd in: (2023) -
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
door: Alam, Tahera
Gepubliceerd in: (2024) -
RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)